Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
PP2A activator, Sphk1 and PKC inhibitor.
Tetracycline; protein translation inhibitor, MM...
Carcinoembryonic antigen epitope.
DAT inhibitor.
β2-adrenergic agonist, BChE inhibitor.
Cathepsin inhibitor.
Decreases expression of MMPs, PGE2, and COX-2, ...
Insect growth regulator; chitin synthesis inhib...
Alkaloid compound found in Corydalis.
Dihydropyridine; L-type Ca2+ channel blocker.
Melatonin analog; MT1/2 agonist, 5-HT2C antagon...
Iridoid glycoside found in Gardenia.
Proteasome inhibitor.
B-Raf and c-Raf inhibitor.
PLK1 inhibitor.
Steroid; glucocorticoid agonist.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Inhibitor of ATM.
ALK inhibitor.
Nucleoside (guanosine) analog; DNA chain termin...